David Rosen – KNSA history
- Issuer:
- KINIKSA PHARMACEUTICALS INTL
- Quarters tracked:
- 9 (Q2 2024 → Q2 2026)
- Current shares:
- 3,999,800
- Current value:
- $255.79M
- Peak shares:
- 4,000,000 (Q3 2025)
- Overall change:
- +65%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 3,999,800 | $255.79M | $63.95 | +249,800 | +7% |
| Q1 2026 | 3,750,000 | $180.56M | $48.15 | +421,347 | +13% |
| Q4 2025 | 3,328,653 | $137.31M | $41.25 | -671,347 | -17% |
| Q3 2025 | 4,000,000 | $155.32M | $38.83 | +90,194 | +2% |
| Q2 2025 | 3,909,806 | $108.18M | $27.67 | +526,567 | +16% |
| Q1 2025 | 3,383,239 | $75.14M | $22.21 | +764,136 | +29% |
| Q4 2024 | 2,619,103 | $51.81M | $19.78 | +200,000 | +8% |
| Q3 2024 | 2,419,103 | $60.45M | $24.99 | 0 | 0% |
| Q2 2024 | 2,419,103 | $45.16M | $18.67 | — | NEW |